|
(L1) 6501.31468-Canakinumab, 150 Mg, Injectable Solution, Ampoule Vial, F.A. 1Ml, Route Of Administration: Subcutaneous, Units. Size: Unit, (L2) 6501.38156-Dexamethasone, 0.7 Mg, Implant, Prefilled Applicator, Route Of Administration: Intravitreal, (L3) 6501.46156-Dulaglutide, 1.5Mg, Prefilled Syringe, Applicator Pen, 5Ml, (L4) 6501.23074-Liraglutide, 6 Mg/Ml, Carpule, 3 Ml, Application System With Dispensing Doses From 0.6 To 1.8 Mg, (L5) 6501.60958-Liraglutide, 6 To 3.0 Mg, 28/11/2025 - 12:00:01, (L6) 6501.3061-Octreotide Lar, Acetate, 20 Mg, Powder For Injectable Suspension, Diluent, In Prefilled Syringe + Application System With Sterile Needle And Vial Adapter, 2.0Ml, Route Of Administration: Intramuscular, (L7) 6501.3062-Octreotida Lar, 30 Mg, 0 Ml, (L8) 6501.2965-Botulinum Toxin Type A, 100 U, Lyophilized Powder For Injection Solution, Route Of Administration: Intramuscular / Others, Adult And Pediatric Use, (L9) 6501.49642-Trametinib, Dimethylsulfoxide, 2Mg, Tablet, Blister, Route Of Administration: Oral, (L10) 6501.57875-Trametinib, 5 Mg, Coated Tablet, (L11) 6501.107537-Respiratory Syncytial Virus A And B Vaccine (Rec), 120 Mcg, Single Dose (0.5 Ml)
|
